ALLR - Allarity Therapeutics, Inc.
1.03
-0.040 -3.883%
Share volume: 643,667
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.07
-0.04
-0.04%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-14-2024 | 08-14-2023 | 11-14-2023 | 11-14-2024 | 05-14-2024 | 08-05-2024 | 11-14-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 3.668 M | 4.156 M | 4.426 M | 4.888 M | 4.240 M | 3.371 M | 2.610 M | |
| Selling general and admin | 2.241 M | 3.051 M | 2.478 M | 2.265 M | 2.070 M | 2.313 M | 1.589 M | |
| Research and development | 1.427 M | 1.105 M | 1.948 M | 2.623 M | 2.170 M | 1.058 M | 1.021 M | |
| Total expenses | 3.668 M | 4.156 M | 4.426 M | 4.888 M | 4.240 M | 3.371 M | 12.313 M | |
| 13.30% | 6.50% | 10.44% | -13.26% | -20.50% | 265.26% | |||
| Operating income | -3.668 M | -4.156 M | -4.426 M | -4.888 M | -4.240 M | -3.371 M | -12.313 M | |
| Ebit | -3.264 M | -2.241 M | -4.425 M | -1.233 M | -3.745 M | -1.256 M | -12.178 M | |
| Pretax income | -3.352 M | -2.380 M | -4.447 M | -1.625 M | -3.847 M | -1.629 M | -11.967 M | |
| -29.00% | 86.85% | -63.46% | 136.74% | -57.66% | 634.62% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 83.000 K | -4.000 K | 0.000 | -377.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.352 M | -2.380 M | -4.447 M | -1.557 M | -3.843 M | -1.629 M | -11.590 M | |
| 29.00% | -86.85% | 64.99% | -146.82% | 57.61% | -611.48% |
